Cargando…
Effect of Alirocumab on Coronary Calcification in Patients With Coronary Artery Disease
BACKGROUND: Proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors have been documented with significantly reduction in LDL cholesterol levels and cardiovascular events. However, evidence regarding the impact of PCSK9 inhibitors on coronary calcification is limited. METHODS: Eligible patie...
Autores principales: | Gao, Fei, Li, Yue Ping, Ma, Xiao Teng, Wang, Zhi Jian, Shi, Dong Mei, Zhou, Yu Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120536/ https://www.ncbi.nlm.nih.gov/pubmed/35600486 http://dx.doi.org/10.3389/fcvm.2022.907662 |
Ejemplares similares
-
Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography
por: Gao, Fei, et al.
Publicado: (2021) -
Therapeutic Exosomes in Prognosis and Developments of Coronary Artery Disease
por: Chen, Ai-Qun, et al.
Publicado: (2021) -
Diagnostic Improvements of Deep Learning–Based Image Reconstruction for Assessing Calcification-Related Obstructive Coronary Artery Disease
por: Yi, Yan, et al.
Publicado: (2021) -
Famine in childhood and postmenopausal coronary artery calcification: a cohort study
por: Idris, Nikmah S, et al.
Publicado: (2013) -
Artificial Intelligence-Enabled ECG Algorithm for the Prediction of Coronary Artery Calcification
por: Han, Changho, et al.
Publicado: (2022)